STOCK TITAN

Jonathan Biller to sell 1,925 VRTX shares worth $886,327.75

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sales of common stock, indicating an intent to sell 1,925 shares through Fidelity Brokerage Services LLC on or around 02/11/2026 on the NASDAQ. The filing lists an aggregate market value of $886,327.75 for these shares and shows 253,718,831 shares of this class outstanding.

The 1,925 shares were acquired on 02/10/2026 through restricted stock vesting from the issuer as compensation. The document also reports that Jonathan Biller sold 347 common shares for $155,803.00 on 12/03/2025 during the past three months.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What share sale is disclosed in this Form 144 related to VRTX?

The filing discloses a planned sale of 1,925 common shares. The shares are expected to be sold through Fidelity Brokerage Services LLC on or about February 11, 2026, on NASDAQ, with an aggregate market value stated as $886,327.75 in the document.

How were the 1,925 VRTX shares being sold under Form 144 acquired?

The 1,925 shares were acquired through restricted stock vesting. The document states they were obtained on February 10, 2026, directly from the issuer as compensation, with the same date listed as the payment date for this compensation-related stock award.

What recent prior sales by the same seller are reported for VRTX stock?

The filing reports a prior sale of 347 common shares. It lists Jonathan Biller as the seller of these shares on December 3, 2025, with gross proceeds of $155,803.00, covering all sales by this person in the last three months.

How many VRTX shares of this class are outstanding in the Form 144?

The document lists 253,718,831 shares of the class outstanding. This figure appears in the securities information section alongside the sale details, providing a baseline context for the 1,925-share planned sale described in the filing.

Which broker and exchange are used for the planned VRTX share sale?

The planned sale is through Fidelity Brokerage Services LLC on NASDAQ. The broker’s address is listed as 900 Salem Street, Smithfield, RI 02917, and NASDAQ is named as the securities exchange for executing the transaction.

Who is identified as a recent seller of VRTX common stock in this filing?

Jonathan Biller is identified as a recent seller of common shares. The document shows his address in Boston, Massachusetts, and records his sale of 347 shares on December 3, 2025, including the gross proceeds from that transaction.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

117.03B
253.12M
0.14%
98.18%
1.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON